rs148110552

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_000393.5(COL5A2):​c.3614T>C​(p.Val1205Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,613,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1205I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000040 ( 0 hom. )

Consequence

COL5A2
NM_000393.5 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5

Conservation

PhyloP100: 2.19

Publications

1 publications found
Variant links:
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
COL5A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, classic type, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000393.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07462087).
BP6
Variant 2-189041605-A-G is Benign according to our data. Variant chr2-189041605-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 333134.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000525 (8/152262) while in subpopulation NFE AF = 0.0000735 (5/68020). AF 95% confidence interval is 0.0000285. There are 0 homozygotes in GnomAd4. There are 4 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 8 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000393.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL5A2
NM_000393.5
MANE Select
c.3614T>Cp.Val1205Ala
missense
Exon 50 of 54NP_000384.2P05997

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL5A2
ENST00000374866.9
TSL:1 MANE Select
c.3614T>Cp.Val1205Ala
missense
Exon 50 of 54ENSP00000364000.3P05997
COL5A2
ENST00000858728.1
c.3611T>Cp.Val1204Ala
missense
Exon 50 of 54ENSP00000528787.1
COL5A2
ENST00000858729.1
c.3506T>Cp.Val1169Ala
missense
Exon 49 of 53ENSP00000528788.1

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152144
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000597
AC:
15
AN:
251430
AF XY:
0.0000589
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000879
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.0000397
AC:
58
AN:
1461450
Hom.:
0
Cov.:
30
AF XY:
0.0000454
AC XY:
33
AN XY:
727064
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33476
American (AMR)
AF:
0.0000224
AC:
1
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000360
AC:
40
AN:
1111628
Other (OTH)
AF:
0.0000828
AC:
5
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152262
Hom.:
0
Cov.:
33
AF XY:
0.0000537
AC XY:
4
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41550
American (AMR)
AF:
0.0000654
AC:
1
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68020
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000127
Hom.:
0
Bravo
AF:
0.0000340
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not provided (2)
-
1
-
Ehlers-Danlos syndrome type 7A (1)
-
-
1
Ehlers-Danlos syndrome, classic type, 1 (1)
-
-
1
Ehlers-Danlos syndrome, classic type, 2 (1)
-
-
1
Familial thoracic aortic aneurysm and aortic dissection (1)
-
-
1
not specified (1)
-
1
-
Telecanthus (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.34
T
Eigen
Benign
-0.73
Eigen_PC
Benign
-0.54
FATHMM_MKL
Benign
0.37
N
LIST_S2
Benign
0.83
T
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.075
T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
-1.1
N
PhyloP100
2.2
PrimateAI
Benign
0.35
T
PROVEAN
Benign
0.88
N
REVEL
Benign
0.23
Sift
Benign
0.83
T
Sift4G
Benign
0.52
T
Varity_R
0.047
gMVP
0.26
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs148110552;
hg19: chr2-189906331;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.